SBWire

The 2012-21 forecast period will see the loss of exclusivity for the leading non-insulin antidiabetic Actos franchise, while new launches include the first once-weekly GLP-1 agonists and the oral SGLT-2 inhibitor class, to compete in an increasingly crowded treatment algorithm in type 2 diabetes.

Providing clarity regarding generic launch timing that will shape the market around Eli Lilly's antidepressant Cymbalta and Celgene's oncology drug Revlimid.

In an effort to streamline R&D activities, Roche is to shut down its research facility in Nutley, New Jersey, resulting in the loss of 1,000 jobs. By 2013, the company will transfer these R&D activities to sites in Switzerland and Germany. Despite the cuts in New Jersey, Roche is looking to establish a new center focusing on translational research on the US east coast.

The South Korean personal accident and health insurance market grew at a healthy rate during the review period (2007-2011). This growth was generated by the country's high traffic accident ratio, ageing population, increased penetration of health insurance products, rising disposable income and improved awareness of the benefits of health insurance. Over the forecast period, the growth in the insurance segment will be driven by the increased participation of private health insurers, as the government implements measures to contain the country's rising public healthcare expenditure.

The global wood-based panel market valued over US$80 billion in 2011, of which the Asia-Pacific market accounted for a 40.6% share and was the largest wood-based panel regional market. It was followed by the European and North American markets, both of which managed to retain their respective positions as the second- and third-largest markets despite the impact of the global financial crisis. Moreover, continuing market uncertainty in Europe and sluggish growth in the US is expected to reduce the market share of both markets over the forecast period, with the Asia-Pacific market expected to gain at their expense due to rapidly increasing demand from continually expanding economies such as China and India. Overall, Timetric expects the share of the European wood-based panel market to fall from 33.6% in 2011 to 28.6% in 2016, and projects that the share of the North American market will fall from 18.1% in 2011 to 14.6% in 2016.

In terms of gross written premiums, the South Korean insurance industry is the world's ninth-largest insurance industry and is, behind Japan and China, the third-largest insurance industry in Asia. Moreover, the industry has grown significantly over the last decade due to an overall increase in consumer awareness of insurance products and South Korea's strong macroeconomic growth, which has resulted in the country now having the highest gross insurance written premiums per capita in Asia and the highest gross written premiums as a percentage of GDP in Asia.

Published by Canadean, this Quarterly Beverage Tracker report provides a detailed analysis of the latest developments in the USA beverage market

Published by Canadean, this Quarterly Beverage Tracker report provides a detailed analysis of the latest developments in the Portugal beverage market

Sports and Leisure Equipment Retailing in G20 to 2016: Market Guide" provides in-depth detail on the trends and drivers of the Sports and Leisure Equipment Retailing market in the G20 region. The report includes quantitative information (historic and forecast market values), segmented at category level.

Books, News and Stationery Retailing in Emerging Markets to 2016: Market Guide" provides in-depth detail on the trends and drivers of the Books, News and Stationery Retailing market in the Emerging Markets. The report includes quantitative information (historic and forecast market values), segmented at category level.

The POC cardiology diagnostics market was worth over US$2 billion in 2011 and rose by 9% compared with 2010. This was driven by a growing interest in the adoption of POC technologies by both healthcare providers and patients at home, as well as the introduction of new products that enable POC testing for more applications, enhance ease-of-use and improve on current products.

GBI Research, a leading business intelligence provider, has released its latest research, "Shale Market in North America to 2016 - Motivated by Surplus Gas Production, Global Energy Players Eyeing Lucrative Asian Markets for Export". The study, which is an offering from the company's Energy Research Group, provides an in-depth analysis of the most significant shale plays in North America, such as Bakken Shale, Barnett Shale, Eagle Ford Shale, Fayetteville Shale, Haynesville Shale/Bossier Shale, Marcellus Shale and Woodford Shale. The report provides detailed information and analysis on the operational overview of all of these shale plays, detailing key characteristics, production trends during 2006-2016, and cost trends, which includes well cost, finding and development cost, drilling activity, and planned rigs. The report also contains competitive analysis, analyzing major companies by both acreage and production, and the planned capital expenditure for 2012 by major companies. It also details the major merger and acquisition activities in these shale plays.

The report contains a detailed description of the power generation company's business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.

The report contains a detailed description of the power generation company's business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.

GlobalData's new report, "New Zealand Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others" provides key market data on the New Zealand Orthopedic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within twelve market categories - Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Trauma Fixation, Arthroscopy, Orthobiologics, Orthopedic Braces and Supports, Orthopedic Bone Cement and Casting Materials, Orthopedic Prosthetics, Other Joint Reconstruction, Cranio Maxillofacial Fixation (CMF) and Orthopedic Tools. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Stena AB Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Stena AB”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, operations and products, and provides an analysis of its key revenue lines.

AvenEx Energy Corp Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “AvenEx Energy Corp”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, operations and products, and provides an analysis of its key revenue lines.

Compton Petroleum Corporation Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Compton Petroleum Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, operations and products, and provides an analysis of its key revenue lines.

Global Markets Direct's, 'Liver Cancer - Pipeline Review, Global Markets Direct's, 'Liver Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Cancer. Liver Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2012', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) therapeutic pipeline. This report provides information on the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD). 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2012', provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) therapeutic pipeline. This report provides information on the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Plaque Psoriasis (Psoriasis Vulgaris). 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Polycystic Ovarian Syndrome - Pipeline Review, H2 2012', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Polycystic Ovarian Syndrome. 'Polycystic Ovarian Syndrome - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Biliary Cirrhosis - Pipeline Review, H2 2012', provides an overview of the Biliary Cirrhosis therapeutic pipeline. This report provides information on the therapeutic development for Biliary Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Biliary Cirrhosis. 'Biliary Cirrhosis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Acute Heart Failure - Pipeline Review, H2 2012', provides an overview of the Acute Heart Failure therapeutic pipeline. This report provides information on the therapeutic development for Acute Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Heart Failure. 'Acute Heart Failure - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Fatty Liver Disease - Pipeline Review, H2 2012', provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the therapeutic development for Fatty Liver Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fatty Liver Disease. 'Fatty Liver Disease - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.